GIP was initially isolated from intestinal extracts and shown to have a potent insulinotropic effect.10, 15, 16 However, clinical studies demonstrated that, in hyperglycemic states, the insulinotropic action of GIP is inhibited, while GLP-1s function remains intact.17, 18 Recent research indicates that GIP is largely responsible for postprandial insulin secretion in T2DM, rather than the opposite.19 In preclinical studies, GIP receptor deficiency in mice leads to impaired glucose tolerance with reduced -cell function,20 while GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved beta cell function and glucose homeostasis.21 Collectively, GLP-1 and GIP seem to work in tandem with GLP-1 inhibiting glucagon secretion when the plasma glucose concentration is high, while GIP acts at lower glucose levels.17, 22 Thus, these two hormones could work together in T2DM as the consistent glucose-lowering effect of GLP-1 could potentiate the role of GIP, whose action is dependent upon the glycemic status

Do not increase the dose without getting a go-ahead from your healthcare provider
Lynsey makes me feel so comfortable and I love her energy
Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review
The trade-off is a fixed concentration: the 32 mg pen and 64 mg pen deliver the same drug per click-unit on the dial, but the 64 mg lasts twice as long at any given maintenance dose